Cohen hearing: Here's what Montana's delegation said - Billings Gazette

-

Asked about their impressions of the public hearing of President Donald Trump's former personal lawyer Michael Cohen, whether Cohen was credible and what action they thought Congress should take next, the Republicans in Montana’s delegation said they didn’t watch the hearing. Democrat Sen. Jon Tester said it was important to let the process play out.

Cohen testified Wednesday to the House Oversight and Reform committee in cooperation with special counsel Robert Mueller's Russia investigation. Cohen begins a three-year prison sentence in May after he pleaded guilty to lying to Congress in 2017 and committing campaign finance violations while he was working for Trump.

“The American people deserve to see those in public life held accountable, and they deserve transparency — so it’s important folks put politics aside and follow the facts and the money regardless of where they may go,” Tester said in an issued statement.

Republicans Sen. Steve Daines and Greg Gianforte didn’t watch the Cohen hearing.

“Aside from having a brief lunch and voting to protect law-abiding gun owners, Greg has been meeting with Montanans all day and hasn’t watched a minute of it,” said Travis Hall, Gianforte’s communications director.

Daines' staff said he didn’t watch and doesn’t find Cohen credible.

“The senator spent the day meeting with Montanans in D.C. He believes it’s important to prioritize Montana, over a sensationalized hearing meant to produce soundbites,” said Julia Doyle, a Daines spokeswoman. Doyle said because Cohen is on his way to prison for lying to Congress once before, Daines believes he lacks credibility.



https://ift.tt/2BWIRB3

Comments

Post a Comment

Popular posts from this blog

Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

-
Image
Medicare Open Enrollment ends December 7. The easy choice is to stay with all-in-one Medicare Advantage instead of switching to Traditional Medicare plus a supplement and drug plan. The hard one is whether to switch between Medicare Advantage plans, from a well-liked one to one accepted at a so-called top-10 hospital. Humana Gold Plus, a Medicare Advantage HMO, has served me well for five years. Hearing aids cost me only $10 after its $2,000 allowance. Routine doctor and dentist appointments and my medication cost nothing. But Humana Gold Plus is not accepted by Northwestern Memorial Hospital, the nearby hospital that US News & World Report ranks as the tenth best in the country, or by Northwestern Medicine physicians. My primary care physician is in an Advocate Medical Group. If I were hospitalized, it would be at Advocate Illinois Masonic Medical Center. If I had a serious illness, I’d see specialists in Advocate’s network. Illinois Masonic is not a second-rate hospital, and
Read more

Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

-
Image
3M did not admit any wrongdoing as part of that settlement. Read 3M's full statement on the ear plugs here. "We deny this product was defectively designed," a company spokesperson said in a statement to 5 INVESTIGATES, adding they will "defend against the allegations in these lawsuits." More than 630 lawsuits have been filed and will be heard in a federal court in Florida. An attorney involved with the multi-district litigation says roughly 30 have been filed by veterans who live in Minnesota. Constant ringing Sarah Kay Carlson, an Army veteran from St. Paul, filed her lawsuit in April, claiming 3M exposed her and thousands of other Marines and soldiers to "extremely dangerous and disabling noise." 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (PDF) 3M Earplug Complaint (Sarah Kay Carlson) Ramsey County (Filed) (Text) Carlson, who was deployed as part of Operation Iraqi Freedom in the late 2000s, provided security to convoys t
Read more

Sickle Cell Disease (SCD): Practice Essentials, Background, Genetics

-
Image
hemophilia c factor 11 :: Article Creator Regeneron Reports Fourth Quarter And Full Year 2023 Financial And Operating Results Fourth quarter 2023 revenues increased 1% to $3.43 billion versus fourth quarter 2022; excluding RonapreveTM(a)(b), revenuesincreased 14% Full year 2023 revenues increased 8% to $13.12 billion versus full year 2022;excluding Ronapreve(a), revenuesincreased 12% Fourth quarter 2023 Dupixent®global net sales(recorded by Sanofi) increased 31% to $3.22 billion versus fourth quarter 2022; full year 2023 Dupixent global net sales increased 33% to $11.59 billion versus 2022 Fourth quarter 2023 U.S. Net sales for EYLEA®HD and EYLEA®were $1.46 billion, including $123 million from EYLEA HD; full year 2023 U.S. Net sales for EYLEA HD and EYLEA were $5.89 billion, including $166 million from EYLEA HD following its August 2023 FDA approval Fourth quarter 2023 Libtayo®global n
Read more